Director, Wright Medical Group N.V.; GenMark Diagnostics; Nevro; and Sientra
Kevin C. O’Boyle
Kevin C. O’Boyle has over 20 years of executive management experience in the medical device industry. He currently serves as a director of Wright Medical Group N.V. (WMGI), a global orthopedics company since June 2010, GenMark Diagnostics (GNMK), a company that provides multiplex molecular diagnostic solutions since March 2010, Nevro (NVRO), a global medical device company focused on the treatment of chronic pain since March 2019 and Sientra (SIEN), a medical aesthetics company since July 2014.
Mr. O’Boyle served as the Senior Vice President and Chief Financial Officer of Advanced BioHealing, a medical device company, from December 2010 until it was acquired in July 2011. From January 2003 until December 2009, Mr. O’Boyle served as Chief Financial Officer of NuVasive, a medical device orthopedics company. Prior to that, he served in various leadership positions during his six years with ChromaVision Medical Systems (CVSN), a medical diagnostics company focused on the oncology market, including as its Chief Financial Officer and Chief Operating Officer. Before that, Mr. O’Boyle spent seven years with Albert Fisher Group PLC (FSH) an international food company, where he held several leadership positions including Chief Financial Officer and Senior Vice President of Operations.
Mr. O’Boyle previously served as a director of each Zeltiq Aesthetics (ZLTQ), a medical device company, from July 2011 until it was acquired in April 2017, Durata Therapeutics (DRTX), a pharmaceutical company, from April 2012 until it was acquired in November 2014, and NeoTract, a medical device company, from April 2017 until it was acquired in October 2017.
Mr. O’Boyle received a Bachelor of Science in Accounting from Rochester Institute of Technology and successfully completed the Executive Management Program at the University of California Los Angeles, John E. Anderson Graduate School of Business.